Chris Robillard
Corporate Officer/Principal at CRINETICS PHARMACEUTICALS, INC.
Profile
Chris Robillard is currently the Chief Business Officer at Crinetics Pharmaceuticals, Inc. He previously worked as the Vice President & Head of Business Development at Goldfinch Bio, Inc. and as the Head of Business Development & Corporate Strategy at Karyopharm Therapeutics, Inc. Mr. Robillard completed his undergraduate degree at Lehigh University and holds an MBA from Pepperdine University.
Chris Robillard active positions
| Companies | Position | Start |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 20/03/2022 |
Former positions of Chris Robillard
| Companies | Position | End |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Chris Robillard
| Lehigh University | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Chris Robillard
